Clinical Trial Update: A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Eto (ethambutol) alone and in combination with BVL-GSK098 for rifampicin- and isoniazid-susceptible pulmonary tuberculosis; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• BVL-GSK098
• Eto (Ethambutol)

Snippet

Sponsor: TASK Applied Science | Conditions: Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) | Phase 2 | Status: COMPLETED